Want to track 8H0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
PolyPeptide Group AG (8H0) Statistics
Valuation metrics
Market Cap -
Enterprise value 55.98M
Trailing P/E (ttm) -64.06
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) -
Enterprise Value/Revenue 0.14
Enterprise Value/EBITDA 1.98
Overview
Shares outstanding 33.01M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 10
Average volume (90 days) 3
Price summary
52-Week low 23
52-Week high 53
Beta -
50-Day moving average 28.53
200-Day moving average 26.49
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.17%
Operating margin -0.02%
Operational effectiveness
Return on assets -0.03%
Return on equity -0.06%
Income Statement
Revenue (ttm) 391.87M
Revenue per share (ttm) 11.88
Quarterly revenue growth (yoy) -
Gross profit (ttm) 66.53M
EBITDA 28.34M
Net income to common (ttm) -21.17M
Diluted EPS (ttm) -0.64
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) 130.56M
Total Debt/Equity (mrq) 0.38
Current ratio (mrq) 1.74%
Book value per share (mrq) -
Cash Flow
Cash flow statement 30.57M
Levered free cash flow (LFCF) -21.17M
